Search filters

List of works by Sheng-Nan Lu

A combination of the on-treatment FIB-4 and alpha-foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir

scientific article published on 12 June 2018

Association between chronic viral hepatitis and metabolic syndrome in southern Taiwan: a large population-based study

scientific article published on 11 September 2018

Editorial: hepatitis B, fatty liver and metabolic syndrome-Interaction or co-existence? Authors' reply

scientific article published on 01 November 2018

Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naïve patients with chronic hepatitis B-related compensated cirrhosis in Taiwan

scientific article published on 27 October 2020

Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir

scientific article published on 28 November 2018

Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank

scientific article published on 23 June 2020

Letter: the association between chronic viral hepatitis and metabolic syndrome - Authors' reply

scientific article published on 01 January 2019

Liver stiffness measurement at complete virological response in hepatoma prediction for HBV-related cirrhosis patient with potent antiviral agent

scientific article published on 20 August 2019

Liver stiffness‐based score at sustained virologic response predicts liver‐related complications after eradication of hepatitis C virus

scientific article published in 2021

The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients.

scientific article

Using AST-platelet ratio index and fibrosis 4 index for detecting chronic hepatitis C in a large-scale community screening

scientific article published on 22 October 2019